Skip to main content
Top
Published in: BMC Health Services Research 1/2018

Open Access 01-12-2018 | Research article

Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan

Authors: Feras Darwish Elhajji, Ghaith M. Al-Taani, Lana Anani, Sahar Al-Masri, Haneen Abdalaziz, Su’ad H. Qabba’h, Abdel Qader Al Bawab, Michael Scott, David Farren, Fiona Gilmore, Ann Versporten, Herman Goossens, Mamoon A. Aldeyab

Published in: BMC Health Services Research | Issue 1/2018

Login to get access

Abstract

Background

To assess antimicrobial prescribing in a Northern Ireland hospital (Antrim Area Hospital (AAH)) and compare them with those of a hospital in Jordan (Specialty Hospital).

Methods

Using the Global-PPS approach, the present study surveyed patients admitted to the hospital in 2015, the prescribed antibiotics, and a set of quality control indicators related to antibiotics.

Results

Ultimately, 444 and 112 inpatients in the AAH and the Specialty Hospital, respectively, were surveyed. For the medical group, 165 inpatients were prescribed 239 antibiotics in the AAH, while 44 patients in the Specialty Hospital were prescribed 65 antibiotics. In relation to the surgical group, 34 inpatients treated for infection were prescribed 66 antibiotics in the AAH, while 41 patients in the Specialty Hospital treated for infection were prescribed 56 antibiotics. For the medical patients, the most frequently prescribed antibiotics in the AAH were a combination of penicillins (18.8%) and penicillins with extended spectrum (18.8%). For the surgical patients, the most frequently prescribed antibiotics in the AAH were imidazole derivatives (24.2%). For the medical and surgical patients in the Specialty Hospital, the most frequently prescribed antibiotics were third-generation cephalosporins (26.2 and 37.5%, respectively). In medical patients, compliance to guidelines was 92.2% in the Specialty Hospital compared to 72.0% in the AAH (p < 0.001). In surgical patients, compliance to guidelines was 92.7% in the Specialty Hospital compared to 81.8% in the AAH (p = 0.012).

Conclusions

The present study highlighted differences in the utilisation of antimicrobials between two hospitals in two distinct regions and benchmarked antibiotic prescriptions across two hospitals.
Literature
1.
go back to reference Hughes AJ, Ariffin N, Huat TL, Molok HA, Hashim S, Sarijo J, et al. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol. 2005;26:100–4.CrossRef Hughes AJ, Ariffin N, Huat TL, Molok HA, Hashim S, Sarijo J, et al. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol. 2005;26:100–4.CrossRef
2.
go back to reference Hajdu A, Samodova OV, Carlsson TR, Voinova LV, Nazarenko SJ, Tjurikov AV, et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in North-Western Russia. J Hosp Infect. 2007;66:378–84.CrossRef Hajdu A, Samodova OV, Carlsson TR, Voinova LV, Nazarenko SJ, Tjurikov AV, et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in North-Western Russia. J Hosp Infect. 2007;66:378–84.CrossRef
3.
go back to reference Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues AM, et al. And ESAC III Hospital care Subproject,Group. European surveillance of antibiotic consumption (ESAC) point prevalence survey 2008: Paediatric antimicrobial prescribing in 32 hospitals of 21 european countries. J Antimicrob Chemother. 2010;65:2247–52.CrossRef Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues AM, et al. And ESAC III Hospital care Subproject,Group. European surveillance of antibiotic consumption (ESAC) point prevalence survey 2008: Paediatric antimicrobial prescribing in 32 hospitals of 21 european countries. J Antimicrob Chemother. 2010;65:2247–52.CrossRef
4.
go back to reference Robert J, Péan Y, Varon E, Bru JP, Bedos JP, Bertrand X, et al. Point prevalence survey of antibiotic use in french hospitals in 2009. J Antimicrob Chemother. 2012;67:1020–6.CrossRef Robert J, Péan Y, Varon E, Bru JP, Bedos JP, Bertrand X, et al. Point prevalence survey of antibiotic use in french hospitals in 2009. J Antimicrob Chemother. 2012;67:1020–6.CrossRef
5.
go back to reference Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 2011;52:S397–428.CrossRef Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 2011;52:S397–428.CrossRef
6.
go back to reference Ciofi Degli Atti ML, Raponi M, Tozzi AE, Ciliento G, Ceradini J, Langiano T. Point prevalence study of antibiotic use in a paediatric hospital in Italy. Euro Surveill. 2008;13:1–4.CrossRef Ciofi Degli Atti ML, Raponi M, Tozzi AE, Ciliento G, Ceradini J, Langiano T. Point prevalence study of antibiotic use in a paediatric hospital in Italy. Euro Surveill. 2008;13:1–4.CrossRef
7.
go back to reference Xie DS, Xiong W, Xiang LL, Fu XY, Yu YH, Liu L, et al. Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei province, China, 2007-2008. J Hosp Infect. 2010;76:150–5.CrossRef Xie DS, Xiong W, Xiang LL, Fu XY, Yu YH, Liu L, et al. Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei province, China, 2007-2008. J Hosp Infect. 2010;76:150–5.CrossRef
8.
go back to reference Zarb P, Goossens H. European surveillance of antimicrobial consumption (ESAC) value of a point-prevalence survey of antimicrobial use across europe. Drugs. 2011;71:745–55.CrossRef Zarb P, Goossens H. European surveillance of antimicrobial consumption (ESAC) value of a point-prevalence survey of antimicrobial use across europe. Drugs. 2011;71:745–55.CrossRef
9.
go back to reference Ceyhan M, Yildirim I, Ecevit C, Aydogan A, Ornek A, Salman N, et al. Inappropriate antimicrobial use in turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis. 2010;14:55–61.CrossRef Ceyhan M, Yildirim I, Ecevit C, Aydogan A, Ornek A, Salman N, et al. Inappropriate antimicrobial use in turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis. 2010;14:55–61.CrossRef
10.
go back to reference Ansari F, Erntell M, Goossens H, Davey P. The european surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 european hospitals in 2006. Clin Infect Dis. 2009;49:1496–504.CrossRef Ansari F, Erntell M, Goossens H, Davey P. The european surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 european hospitals in 2006. Clin Infect Dis. 2009;49:1496–504.CrossRef
11.
go back to reference Usluer G, Ozgunes I, Leblebicioglu H. Turkish antibiotic utilization study G. a multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16–21.CrossRef Usluer G, Ozgunes I, Leblebicioglu H. Turkish antibiotic utilization study G. a multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16–21.CrossRef
12.
go back to reference Ang L, Laskar R, Gray JW. A point prevalence study of infection and antimicrobial use at a UK children’s hospital. J Hosp Infect. 2008;68:372–4.CrossRef Ang L, Laskar R, Gray JW. A point prevalence study of infection and antimicrobial use at a UK children’s hospital. J Hosp Infect. 2008;68:372–4.CrossRef
13.
go back to reference Astagneau P, Fleury L, Leroy S, Lucet JC, Golliot F, Regnier B, et al. Cost of antimicrobial treatment nosocomial infections based on a French prevalence survey. J Hosp Infect. 1999;42:303–12.CrossRef Astagneau P, Fleury L, Leroy S, Lucet JC, Golliot F, Regnier B, et al. Cost of antimicrobial treatment nosocomial infections based on a French prevalence survey. J Hosp Infect. 1999;42:303–12.CrossRef
14.
go back to reference Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: report of 12 point-prevalence studies on antibiotic use in a university hospital. Scand J Infect Dis. 2002;34:56–60.CrossRef Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: report of 12 point-prevalence studies on antibiotic use in a university hospital. Scand J Infect Dis. 2002;34:56–60.CrossRef
15.
go back to reference Seaton RA, Nathwani D, Burton P, McLaughlin C, MacKenzie AR, Dundas S, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow antimicrobial audit tool (GAAT). Int J Antimicrob Agents. 2007;29:693–9.CrossRef Seaton RA, Nathwani D, Burton P, McLaughlin C, MacKenzie AR, Dundas S, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow antimicrobial audit tool (GAAT). Int J Antimicrob Agents. 2007;29:693–9.CrossRef
16.
go back to reference Ufer M, Radosević N, Vogt A, Palcevski G, Francetić I, Reinalter SC, et al. Antimicrobial drug use in hospitalized paediatric patients: a cross-national comparison between Germany and Croatia. Pharmacoepidemiol Drug Saf. 2005;14:735–9.CrossRef Ufer M, Radosević N, Vogt A, Palcevski G, Francetić I, Reinalter SC, et al. Antimicrobial drug use in hospitalized paediatric patients: a cross-national comparison between Germany and Croatia. Pharmacoepidemiol Drug Saf. 2005;14:735–9.CrossRef
17.
go back to reference Vlahović-Palcevski V, Dumpis U, Mitt P, Gulbinovic J, Struwe J, Palcevski G, et al. Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect. 2007;13:277–83.CrossRef Vlahović-Palcevski V, Dumpis U, Mitt P, Gulbinovic J, Struwe J, Palcevski G, et al. Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect. 2007;13:277–83.CrossRef
18.
go back to reference Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother. 2007;51:864–7.CrossRef Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother. 2007;51:864–7.CrossRef
19.
go back to reference Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6:e619–29.CrossRef Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6:e619–29.CrossRef
20.
go back to reference Humphreys H, Newcombe RG, Enstone J, Smyth ET, McIlvenny G, Fitzpatrick F, et al. Four country healthcare associated infection prevalence survey 2006: risk factor analysis. J Hosp Infect. 2008;69:249–57.CrossRef Humphreys H, Newcombe RG, Enstone J, Smyth ET, McIlvenny G, Fitzpatrick F, et al. Four country healthcare associated infection prevalence survey 2006: risk factor analysis. J Hosp Infect. 2008;69:249–57.CrossRef
21.
go back to reference Horikoshi Y, Suwa J, Higuchi H, Kaneko T, Furuichi M, Aizawa Y, et al. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Int J Infect Dis. 2017;1(64):69–73.CrossRef Horikoshi Y, Suwa J, Higuchi H, Kaneko T, Furuichi M, Aizawa Y, et al. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Int J Infect Dis. 2017;1(64):69–73.CrossRef
22.
go back to reference Karki S, Houston L, Land G, Bass P, Kehoe R, Borrell S, et al. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control. 2012;1:31.CrossRef Karki S, Houston L, Land G, Bass P, Kehoe R, Borrell S, et al. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control. 2012;1:31.CrossRef
23.
go back to reference van Spreuwel PCJM, Blok H, Langelaar MFM, Kullberg BJ, Mouton JW, Natsch S. Identifying targets for quality improvement in hospital antibiotic prescribing. Neth J Med. 2012;73:161–8. van Spreuwel PCJM, Blok H, Langelaar MFM, Kullberg BJ, Mouton JW, Natsch S. Identifying targets for quality improvement in hospital antibiotic prescribing. Neth J Med. 2012;73:161–8.
24.
go back to reference Sikkens JJ, van Agtmael MA, Peters EJG, Lettinga KD, van der Kuip M, Vandenbroucke-Grauls CMJE, et al. Behavioral approach to appropriate antimicrobial prescribing in hospitals: the Dutch unique method for antimicrobial stewardship (DUMAS) participatory intervention study. JAMA Intern Med. 2017;177(8):1130–8.CrossRef Sikkens JJ, van Agtmael MA, Peters EJG, Lettinga KD, van der Kuip M, Vandenbroucke-Grauls CMJE, et al. Behavioral approach to appropriate antimicrobial prescribing in hospitals: the Dutch unique method for antimicrobial stewardship (DUMAS) participatory intervention study. JAMA Intern Med. 2017;177(8):1130–8.CrossRef
25.
go back to reference Aldeyab MA, Kearney MP, McElnay JC, Magee FA, Conlon G, Gill D, et al. A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin Pharmacol. 2011;71:293–6.CrossRef Aldeyab MA, Kearney MP, McElnay JC, Magee FA, Conlon G, Gill D, et al. A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin Pharmacol. 2011;71:293–6.CrossRef
26.
go back to reference Aldeyab MA, Kearney MP, McElnay JC, Magee FA, Conlon G, MacIntyre J, et al. A point prevalence survey of antibiotic use in four acute-care teaching hospitals utilizing the European surveillance of antimicrobial consumption (ESAC) audit tool. Epidemiol Infect. 2012;140:1714–20.CrossRef Aldeyab MA, Kearney MP, McElnay JC, Magee FA, Conlon G, MacIntyre J, et al. A point prevalence survey of antibiotic use in four acute-care teaching hospitals utilizing the European surveillance of antimicrobial consumption (ESAC) audit tool. Epidemiol Infect. 2012;140:1714–20.CrossRef
27.
go back to reference Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012;17:20316.CrossRef Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012;17:20316.CrossRef
28.
go back to reference Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, et al. Prevalence of antimicrobial use in US acute care hospitals, may-September 2011. JAMA. 2014;312:1438–46.CrossRef Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, et al. Prevalence of antimicrobial use in US acute care hospitals, may-September 2011. JAMA. 2014;312:1438–46.CrossRef
29.
go back to reference Talaat M, Saied T, Kandeel A, El-Ata GAA, El-Kholy A, Hafez S, et al. A point prevalence survey of antibiotic use in 18 hospitals in Egypt. Antibiotics. 2014;3:450–60.CrossRef Talaat M, Saied T, Kandeel A, El-Ata GAA, El-Kholy A, Hafez S, et al. A point prevalence survey of antibiotic use in 18 hospitals in Egypt. Antibiotics. 2014;3:450–60.CrossRef
30.
go back to reference Nair V, Sharma D, Sahni AK, Grover N, Shankar S, Jaiswal SS, et al. Antimicrobial use and antimicrobial resistance in nosocomial pathogens at a tertiary care hospital in Pune. Send to Med J Armed Forces India. 2015;71:112–9.CrossRef Nair V, Sharma D, Sahni AK, Grover N, Shankar S, Jaiswal SS, et al. Antimicrobial use and antimicrobial resistance in nosocomial pathogens at a tertiary care hospital in Pune. Send to Med J Armed Forces India. 2015;71:112–9.CrossRef
31.
go back to reference Akhloufi H, Streefkerk RH, Melles DC, de Steenwinkel JEM, Schurink CAM, Verkooijen RP, et al. Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital. Eur J Clin Microbiol Infect Dis. 2015;34:1631–7.CrossRef Akhloufi H, Streefkerk RH, Melles DC, de Steenwinkel JEM, Schurink CAM, Verkooijen RP, et al. Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital. Eur J Clin Microbiol Infect Dis. 2015;34:1631–7.CrossRef
32.
go back to reference Sinatra I, Carubia L, Marchese V, Aprea L, D’ALESSANDRO N, Mammina C, et al. Prevalence survey of healthcare-associated infections and antimicrobial use at the university hospital “Paolo Giaccone”, Palermo, Italy. J Prev Med Hyg. 2013;54:200.PubMedPubMedCentral Sinatra I, Carubia L, Marchese V, Aprea L, D’ALESSANDRO N, Mammina C, et al. Prevalence survey of healthcare-associated infections and antimicrobial use at the university hospital “Paolo Giaccone”, Palermo, Italy. J Prev Med Hyg. 2013;54:200.PubMedPubMedCentral
33.
go back to reference Aqel AA, Giakkoupi P, Alzoubi H, Masalha I, Ellington MJ, Vatopoulos A. Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: a pilot study. J Infect Public Health. 2017;10:150–5.CrossRef Aqel AA, Giakkoupi P, Alzoubi H, Masalha I, Ellington MJ, Vatopoulos A. Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: a pilot study. J Infect Public Health. 2017;10:150–5.CrossRef
34.
go back to reference Holen Ø, Alberg T, Blix HS, Smith I, Neteland MI, Eriksen HM. Broad-spectrum antibiotics in Norwegian hospitals. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. 2016;137(362):2016. Holen Ø, Alberg T, Blix HS, Smith I, Neteland MI, Eriksen HM. Broad-spectrum antibiotics in Norwegian hospitals. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. 2016;137(362):2016.
35.
go back to reference Malcolm W, Nathwani D, Davey P, Cromwell T, Patton A, Reilly J, et al. From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob Resist Infect Control. 2013;2:3.CrossRef Malcolm W, Nathwani D, Davey P, Cromwell T, Patton A, Reilly J, et al. From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob Resist Infect Control. 2013;2:3.CrossRef
36.
go back to reference Cairns KA, Roberts JA, Cotta MO, Cheng AC. Antimicrobial stewardship in Australian hospitals and other settings. Infect Dis Ther. 2015;4:27–38.CrossRef Cairns KA, Roberts JA, Cotta MO, Cheng AC. Antimicrobial stewardship in Australian hospitals and other settings. Infect Dis Ther. 2015;4:27–38.CrossRef
Metadata
Title
Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan
Authors
Feras Darwish Elhajji
Ghaith M. Al-Taani
Lana Anani
Sahar Al-Masri
Haneen Abdalaziz
Su’ad H. Qabba’h
Abdel Qader Al Bawab
Michael Scott
David Farren
Fiona Gilmore
Ann Versporten
Herman Goossens
Mamoon A. Aldeyab
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2018
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-3656-y

Other articles of this Issue 1/2018

BMC Health Services Research 1/2018 Go to the issue